Particle Data Platform

Reclassification isn’t new evidence

18:0421:04 · 181s

On proposed U.S. recategorization of peptides, Leigh clarifies it allows compounding without adding human data, raising tough liability questions and preventing conflation with FDA approval.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.